Showing results (181-190 of 264) with videos related to
Sort By:
Pageof 27
The Lancet. Rheumatology|January 27, 2024
Safety and efficacy of tofacitinib up to 48 months in patients with active psoriatic arthritis: final analysis of the OPAL Balance long-term extension studyPeter Nash, Laura C Coates, Dona Fleishaker, et al.The Journal of Rheumatology|March 2, 2021
Composite Measures for Routine Clinical Practice in Psoriatic Arthritis: Testing of Shortened Versions in a UK Multicenter StudyWilliam Tillett, Oliver FitzGerald, Laura C Coates, et al.Rheumatology and Therapy|March 30, 2022
Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2)Georg Schett, Matthew J Loza, Arumugam Palanichamy, et al.The Journal of Rheumatology|July 9, 2008
Clues to the pathogenesis of psoriasis and psoriatic arthritis from imaging: a literature reviewLaura C Coates, R Rox Anderson, Oliver Fitzgerald, et al.The Journal of Rheumatology. Supplement|June 3, 2019
The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement SetYing Ying Leung, Ana-Maria Orbai, Alexis Ogdie, et al.The Journal of Rheumatology|August 13, 2009
Synovial tissue sublining CD68 expression is a biomarker of therapeutic response in rheumatoid arthritis clinical trials: consistency across centersBarry Bresnihan, Eliza Pontifex, Rogier M Thurlings, et al.Irish Journal of Medical Science|May 12, 2018
Updated pharmacological management of rheumatoid arthritis for women before, during, and after pregnancy, reflecting recent guidelinesKieran E Murray, Louise Moore, Celine O'Brien, et al.Irish Journal of Medical Science|May 27, 2019
A multidisciplinary approach to reproductive healthcare in women with rheumatic diseaseKieran Murray, Louise Moore, Celine O'Brien, et al.RMD Open|March 21, 2018
4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritisDésirée van der Heijde, Atul Deodhar, Oliver FitzGerald, et al.Arthritis Research & Therapy|December 25, 2013
Comparison of remission criteria in a tumour necrosis factor inhibitor treated rheumatoid arthritis longitudinal cohort: patient global health is a confounderEmese Balogh, Joao Madruga Dias, Carl Orr, et al.Pageof 27